Dolaro

Anthropic IPO Date (Late Nov 2026) & How to Buy ANT in Australia

📈 Stocks & ETFs19 min readFeatured

Anthropic IPO expected before 26 November. CommSec, Macquarie, Stake and 5 more brokers run the Australian offer. Likely share price, how to apply and risks.


Quick answer (updated 8 November 2026): No official date yet, but Anthropic is expected to go public before US Thanksgiving on 26 November. Bloomberg reported the roadshow, when banks pitch the shares to big investors, could start the week of 9 November. ANT will list on the Nasdaq only, not the ASX. Australians can apply for shares through an Australian retail offer: CommSec is the lead retail broker, with Macquarie, Morgans, Bell Potter, LGT, Stake, Morgan Stanley Wealth Management and Sharesies also taking part. The amended S-1 filed on 2 November still has no price range. Reported valuations now run from about US$1 trillion to US$1.5 trillion, which works out to roughly US$59 to US$89 per share.

Anthropic's float is the first big AI listing since SpaceX's record IPO in June, and it's a different kind of company. SpaceX listed with a profitable Starlink business attached. Anthropic is a pure AI company whose revenue grew 1,127% year on year in the September 2026 quarter. Its filing also shows a US$104 billion net loss over the first nine months of 2026, most of it an accounting charge rather than cash.

Below is what the filing actually says, what the share price is likely to be, how Australians can get access (including before listing), a tax catch that applies to anyone buying this year, and the risks the prospectus spells out.

What the S-1 reveals about Anthropic's finances

Every figure in this table comes from the original S-1 or the amended S-1 filed on 2 November 2026, which added September quarter results. All amounts are in US dollars.

PeriodRevenueOperating lossNet loss
2023$41 million$551 million$1.5 billion
2024$386 million$3.0 billion$8.3 billion
2025$4.6 billion$8.1 billion$42.0 billion
Six months to 30 June 2026$16.3 billion$693 million$80.7 billion
Nine months to 30 September 2025$2.5 billion$5.2 billion$25.1 billion
Nine months to 30 September 2026$33.2 billion$1.3 billion$104.0 billion

Three things in the filings stand out:

  • Revenue is concentrated in the most recent quarters. Revenue was $11.6 billion in the June 2026 quarter, which produced an operating profit of $1.0 billion, the first time the business made money from its operations. The September quarter brought in nearly $17 billion, up 1,127% on a year earlier, but slipped back to an operating loss of about $567 million (a 3% negative operating margin).
  • The biggest cost is compute, meaning the chips and data centres used to train and run the models. Compute and infrastructure cost $8.9 billion in the first half of 2026. Since 31 December 2025, Anthropic has also signed agreements with future minimum payments of about $417 billion. These are mostly compute leases and cloud commitments, with terms of up to 20 years.
  • The customer base is fairly spread. No single customer made up more than 10% of revenue in the nine months to 30 September 2026, but the top five made up about 25%.

Why the net loss is so much bigger than the operating loss

The US$104 billion nine-month loss is the number in most headlines, and on its own it's misleading. According to the amended S-1, $94.3 billion of it came from changes in the fair value of convertible notes, derivatives and SAFEs ($72.4 billion of that in the first half alone). A SAFE (simple agreement for future equity) is an early-stage funding contract that turns into shares later.

The accounting works like this. Anthropic raised money through instruments that later convert into shares. When the company's valuation rises, those instruments become worth more to the people holding them, and Anthropic has to record that increase as a loss. The S-1 says the charge was largest in the June 2026 quarter, because of the US$65 billion Series H round at a US$965 billion post-money valuation in May.

No cash was spent on that $94.3 billion. The filing says these charges stop once the instruments convert to equity, which mostly happens at the IPO. Look at the operating line, not the net loss, to see whether the business itself is making money.

Advertisement

Anthropic's valuation and the likely IPO share price

Anthropic hasn't published a price range yet. The 2 November amended S-1 still reads "between $ and $" on its cover. The range will be added in a further amendment shortly before the roadshow. In the meantime, three things give a reasonable estimate.

How the valuation has climbed

DateEventAmount raisedValuation (post-money)
September 2025Anthropic Series FUS$13 billionUS$183 billion
February 2026Anthropic Series GUS$30 billionUS$380 billion
March 2026OpenAI round (for comparison)US$122 billionUS$852 billion
May 2026Anthropic Series HUS$65 billionUS$965 billion
November 2026 (expected)Anthropic IPOReported up to US$100 billionUS$1.5 to US$2 trillion reported at filing, since talked down to US$1 to US$1.5 trillion
Anthropic private valuations vs OpenAI
Anthropic Series F (Sep 2025)US$183b
Anthropic Series G (Feb 2026)US$380b
OpenAI (Mar 2026)US$852b
Anthropic Series H (May 2026)US$965b

The valuation rose more than fivefold in about eight months. For comparison, OpenAI closed its US$122 billion round on 31 March 2026. Anthropic's May round put it ahead of OpenAI for the first time.

What that means per share

The S-1 doesn't give a total share count, but it does give enough to work one out. It says the 846,840,960 shares given to its new Public Benefit Fund equal 5% of fully diluted shares as at 30 June 2026. That implies roughly 16.9 billion shares in total. Dividing a valuation by that number gives an approximate share price:

IPO valuationApproximate price per shareWhere the valuation figure comes from
US$1.0 trillion~US$59One investor told the Wall Street Journal the IPO could end up closer to US$1 trillion (7 November)
US$1.5 trillion~US$89The company's reported target, per the WSJ; also the low end of expectations reported by the Financial Times at filing
US$1.75 trillion~US$103High end of the FT-reported range
US$1.9 trillion~US$112Debut market cap implied by IG's pre-IPO grey market
US$2.0 trillion~US$118Earlier reports of a US$100 billion raise

These are our estimates, not forecasts. Expectations have fallen since the filing as markets cooled on AI stocks, and one investor told the WSJ the IPO could be postponed, though Anthropic hasn't announced any delay. The real price will differ for three reasons. New shares issued in the IPO increase the share count. The fully diluted figure assumes Amazon's convertible notes convert in full. And the banks set the final price based on demand during the roadshow. Prediction markets such as Polymarket and Kalshi carry odds on the price, but those are bets, not valuations, and the official range in the amended S-1 is the figure to rely on.

On the first trading day, the price you pay on the Nasdaq can be well above the IPO price. SpaceX priced at US$135 and closed its first day at US$160.95, as covered in our SpaceX IPO guide.

How Australians can get Anthropic shares

ANT will trade only on the Nasdaq, in US dollars. The S-1 says Anthropic does not intend to list its Class A shares on any exchange outside the US, and that includes the ASX. Here's where each route stood on 8 November 2026:

RouteHow it worksStatus at 8 November 2026
Australian public offerApply for shares at the IPO price through the Australian offerConfirmed. CommSec is lead retail broker, with seven other brokers taking part. The ASIC prospectus hasn't been lodged yet, so the offer isn't open
Broker promotionsSome brokers are offering shares as a sign-up incentiveIG Australia is offering one ANT share to new share-trading customers, priced at the IPO price or lower
Nasdaq on-marketBuy ANT through any broker with US market access once trading startsOpen to everyone from the first trading day. Listing is expected before 26 November
Pre-IPO derivativesBet on the debut valuation with a CFD or futures contractAvailable now through some providers. You never own a share
ETFs and indirect exposureOwn a fund or company that holds Anthropic stockAvailable now, but Anthropic is only a small part of what you're buying

The Australian offer

The S-1 lists Australia alongside Canada, parts of the European Economic Area, Japan, Switzerland and the UK as places with their own public offers. The amended S-1 says Australian retail investors must apply under a separate "Australian Prospectus" that complies with the Corporations Act and "will be lodged with the Australian Securities and Investments Commission". SpaceX followed the same model, with a short application window that closed two days before listing.

The brokers taking part are CommSec (lead), Macquarie, Morgans, Bell Potter, LGT Wealth Management, Stake, Morgan Stanley Wealth Management Australia and Sharesies. CommSec says you'll need an active CommSec International Shares Account to apply through it. Each broker sets its own eligibility rules.

Expect a tight timeline. The Australian prospectus can't be lodged until the price range is set, and the window may only be open for a few days. If you want to apply, open and verify an account with one of the eight brokers now, and fund it in advance.

Don't expect a full allocation. The SpaceX offer was heavily oversubscribed, and most retail applicants got only part of what they asked for or nothing.

Buying on the Nasdaq after listing

This is the route most Australians will actually use. The steps are the same as for any US share: open an account with a broker that has Nasdaq access, complete a W-8BEN form, convert AUD to USD and place an order for ANT. Our guide to investing in US shares from Australia covers each step. For the fee differences between two of the most popular platforms, see Stake vs CommSec.

On a one-off purchase, the currency conversion fee usually costs more than the brokerage. Work out the total cost in dollars before you choose a platform.

Can you buy Anthropic shares before the IPO?

Not directly. Anthropic is still a private company, and its shares can't be bought on any exchange until listing day. What's on offer before then are derivatives, contracts that track the expected valuation without giving you any shares:

  • IG's pre-IPO grey market. This is a CFD (contract for difference) priced on Anthropic's total market capitalisation, not a share price. It settles in cash against the official market cap at the close of the first day of trading. IG warns that CFDs "come with a high risk of losing money rapidly due to leverage" and that "you do not own or have any interest in the underlying asset".
  • OKX pre-IPO perpetual futures. OKX Australia launched Anthropic and OpenAI pre-IPO futures on 27 October 2026 with leverage of up to 10x. They're only open to wholesale clients, not everyday retail investors.

Both are leveraged bets on a single number on a single day. If Anthropic debuts below the market's expectations, losses can be larger than your deposit. They aren't a way to own Anthropic.

Anthropic ETFs and other indirect exposure

A few US-listed funds already hold Anthropic stock bought in private rounds. For example, KraneShares' AGIX artificial intelligence ETF had a 2.91% allocation to Anthropic as at 15 April 2026. You'd need a broker with US market access to buy it, and about 97% of the fund is other companies.

No ASX-listed ETF holds Anthropic before it lists. After listing, the quickest route into ASX funds is the Nasdaq 100. Nasdaq's fast entry rule lets a new listing whose market cap ranks among the top 40 index members join after 15 trading days, with at least five trading days' notice. At US$1 trillion or more, ANT would clear that easily. Nasdaq 100 trackers on the ASX, such as BetaShares NDQ and HNDQ, would then hold it automatically. Our Nasdaq ETF guide compares them.

Amazon and Alphabet (Google) are both Anthropic investors and cloud providers to it. The S-1 shows Amazon's convertible notes are capped so it can't hold more than 12% of Anthropic's capitalisation unless it chooses to waive that limit. Anthropic is a small part of what either company is worth, so buying them is a broad tech bet with a little Anthropic exposure, not a substitute for owning ANT.

Advertisement

What you're buying: the voting structure

ANT shares are Class A common stock, with one vote per share. That's only part of the picture. The S-1 sets up a share structure that keeps control away from public shareholders:

  • Class F stock. One share goes to an entity owned by Anthropic's seven co-founders. It carries 50.1% of total voting power on general shareholder matters, however many Class A shares are on issue.
  • Class T stock. One share is held by the Long-Term Benefit Trust (LTBT), a group of trustees with no financial stake in the company. It can elect and remove a majority of the board.
  • Class N stock. Held mainly by strategic partners. It has no voting rights.

Anthropic is also a public benefit corporation. That means its directors are legally required to weigh its stated purpose, "the responsible development and maintenance of advanced AI for the long-term benefit of humanity", against shareholder returns. Nasdaq treats it as a "controlled company", which exempts it from some board-independence rules.

In practice, buying ANT gets you a share of the economics but almost no say over decisions. SpaceX's Class A buyers are in the same position with Elon Musk. The difference is that Anthropic's charter explicitly allows the board to put its mission ahead of your returns.

The tax catch for Australians buying in 2026

If you sell ANT for more than you paid, you'll pay Australian capital gains tax (CGT), worked out in Australian dollars. The rule many guides still repeat, that holding for 12 months halves the taxable gain, no longer works the way it used to.

Act No. 49 of 2026 replaces the 50% CGT discount with cost base indexation and a 30% minimum tax rate for gains made from 1 July 2027. Indexation means your purchase price is increased in line with inflation before the gain is worked out. If you buy ANT in November 2026, you can't reach 12 months of ownership until November 2027. That's after the new rules start. Any gain from 1 July 2027 onwards is taxed under indexation, not the old halving.

That matters most for a stock like ANT, where a large gain or loss could happen quickly. Our CGT changes from 1 July 2027 explainer covers the transitional rules for assets you already hold on that date.

Compare your after-tax result under both systems with our CGT Comparison Calculator. Enter a hypothetical purchase price, sale price and holding period to see what the change costs you.

Two more points for your tax return:

  • Currency counts. Your gain is worked out in AUD using the exchange rate on the day you buy and the day you sell. A falling Australian dollar increases a gain, and a rising one reduces it.
  • Don't expect dividends. The S-1 says Anthropic does not anticipate paying cash dividends in the foreseeable future. Any return will come from the share price.

Advertisement

The risks in Anthropic's own prospectus

The risk factors section of an S-1 is where a company has to disclose what could go wrong. Anthropic's is unusually direct:

  1. Growth may slow sharply. The S-1 says Anthropic does "not expect our revenue will continue to grow at comparable rates" and "cannot assure you that it will continue to grow at all". Its recent growth "may reflect early-stage adoption dynamics".
  2. Compute obligations are fixed, but revenue isn't. About $417 billion of committed payments run for up to 20 years. Many of the largest customers aren't on long-term contracts and can cut their spending at any time, according to the filing.
  3. AI liability may not be insurable. The company warns that "our contractual protections and insurance may be insufficient" to cover harms caused by its models.
  4. The company names catastrophic risk. The filing acknowledges concerns that advanced AI could "pose catastrophic or existential risks to humanity". It also warns that stricter AI regulation could hurt the business.
  5. Shares will come onto the market after the IPO. Insiders have signed lock-up agreements, which stop them selling for a set period. The S-1 says these include "specified early expiration provisions", and lists expected lock-up releases as a factor that could push the price down.
  6. Valuation. The last private round valued Anthropic at US$965 billion. Annualise the September 2026 quarter's revenue of nearly US$17 billion and you get roughly US$68 billion a year. At a US$1.5 trillion IPO valuation, that's about 22 times sales. The price will depend heavily on growth continuing at its current pace.

For Australian investors, there's also currency risk on top: a USD-priced stock can lose value in AUD even when its share price doesn't move.

A sensible way to think about it

If you want to own ANT, keep the position small enough that a 30% fall in a week wouldn't change your plans. Consider waiting for at least one quarterly result as a listed company before buying more. If what you really want is broad AI exposure, a diversified technology ETF spreads the risk across many companies.

See how a single position fits into your wider portfolio with our ETF Calculator. Model a diversified core with a small satellite holding alongside it.

Frequently asked questions

When is the Anthropic IPO date?

No official date has been set, but Anthropic is expected to list on the Nasdaq before US Thanksgiving on 26 November 2026. Bloomberg reported the roadshow could start the week of 9 November, and pricing has been reported for 19 or 20 November. Anthropic filed its S-1 on 26 October and an amended S-1 on 2 November. The price range still has to be set and the registration statement declared effective before trading can start.

What will the Anthropic IPO price per share be?

Anthropic hasn't set a price range yet. The S-1 implies about 16.9 billion fully diluted shares. Reported valuations have fallen from US$1.5–2 trillion at filing to US$1–1.5 trillion, which works out to roughly US$59 to US$89 per share. The official range will appear in a further amended S-1 shortly before pricing.

Can I buy Anthropic shares before the IPO?

Not directly. Before listing, Australians can only take pre-IPO derivative positions, such as IG's grey market CFD on Anthropic's debut market cap. These are leveraged, cash-settled and never give you shares. Some US-listed funds, such as KraneShares AGIX, hold a small slice of Anthropic stock.

Is there an Anthropic ETF on the ASX?

Not before it lists. After listing, Nasdaq's fast entry rule lets a top-40-sized company join the Nasdaq 100 after 15 trading days, so Nasdaq 100 ETFs on the ASX such as NDQ and HNDQ would then hold ANT.

Is Anthropic worth more than OpenAI?

On their last private rounds, yes. Anthropic was valued at US$965 billion in May 2026, compared with OpenAI's US$852 billion in March 2026. Anthropic's IPO is reported to target about US$1.5 trillion, though some investors expect closer to US$1 trillion.

Can I buy Anthropic shares on the ASX?

No. Anthropic will list only on the Nasdaq Global Select Market under the ticker ANT, and its S-1 says it doesn't intend to list on any exchange outside the US. Australians need a broker with US market access, or a place in the Australian public offer.

Is there an Anthropic IPO offer for Australian retail investors?

Yes. CommSec is the lead Australian retail broker, with Macquarie, Morgans, Bell Potter, LGT Wealth Management, Stake, Morgan Stanley Wealth Management Australia and Sharesies also taking part. Applications open once a separate Australian prospectus is lodged with ASIC, which hadn't happened as at 8 November 2026. The size of the Australian allocation hasn't been announced.

Why did Anthropic lose US$104 billion?

Most of it was an accounting charge, not cash. Over the nine months to 30 September 2026, US$94.3 billion came from the rising fair value of convertible notes and similar instruments as Anthropic's valuation increased. The operating loss for the same period was about US$1.3 billion.

Will Anthropic pay dividends?

Not in the foreseeable future, according to the S-1. Any return for shareholders would come from share price growth.

Do I get voting rights if I buy ANT shares?

Class A shares carry one vote each. However, a single Class F share held by the seven co-founders carries 50.1% of total voting power, and the Long-Term Benefit Trust elects a majority of the board. Public shareholders have very little influence over company decisions.

How is Anthropic stock taxed in Australia?

Gains are subject to Australian capital gains tax, worked out in AUD. For gains made from 1 July 2027, the 50% CGT discount is replaced by cost base indexation and a 30% minimum tax rate, so anyone buying in late 2026 won't get the old discount on most of their gain.

Advertisement

Related calculators and guides

This article is for general information only and does not constitute financial, tax or legal advice. Individual circumstances vary. Consult a registered tax agent or licensed financial adviser before making decisions based on this information.

MP

Written by

Mahi Patil

Software engineer & personal finance enthusiast · Melbourne, Australia

Built Dolaro.com.au to create accurate, free Australian finance tools. Invests in Australian and global ETFs and writes about the topics researched firsthand. More about Mahi →

Last updated: · By Mahi Patil

This article is general information only and does not constitute financial advice.

More Stocks & ETFs guides

← All Stocks & ETFs articles